An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
About Hillcrest Primary Care
Hillcrest Primary Care provides preventative care, patient education and treatment of acute and chronic illnesses. We help you monitor your health through regular wellness exams and screenings. Our providers offer primary care services to patients aged 17 and older.
The clinic’s hours of operation are Monday-Friday, 8 a.m. – 5 p.m.